Abstract
INTRODUCTION
Biology is following a path that is reminiscent of the early electronics
industry: a miniaturization and large-scale integration process that will
revolutionize life science research, drug discovery and development, medical
diagnostics and biotechnology. The ongoing miniaturization and large-scale
integration process is encompassed in devices known as biochips, including
microarrays and lab-on-a-chip microfluidic devices. Biochips represent a
diverse group of nanotechnologies that can be expected to exert a significant
impact in life science research, diagnostics and medicine.
DNA microarrays are already an established technology generating substantial
revenue derived from gene expression, SNP analysis and gene resequencing. The
first DNA microarray has recently been approved by the FDA for in-vitro
diagnostic applications, and significant market growth can be expected in this
application area. Protein microarrays are gaining prominence in the
marketplace, while future, emerging array technologies including tissue/cell
and glycomics arrays are increasing in importance. Lab-on-chip devices are
also making rapid progress in important pharmaceutical and diagnostics market
segments.
SCOPE OF STUDY
This report contains:
- Descriptions of various biochips including current and potential
applications
- The current market status of biochip products, trends and forecasts for
growth over the next 5 to 10 years
- Technological issues, including the latest advances
- A discussion of driving forces in the biochip industry on a global basis,
including large-scale integration, research initiatives and drug discovery
- An examination of biochip companies and industry alliances.
METHODOLOGY
Based on our analysis, we evaluate the potential applications of biochips in
each of the major market segments, and forecast sales revenues for 2008
through 2013.
For research tools and drug discovery and development, the study presents a
forecast from 2008 through 2013 for each of the important products and
technologies. For diagnostics, the report forecasts from 2008 through 2013 the
demand for microarrays and lab-on-a-chip devices by analysis type. Finally,
this study forecasts from 2008 through 2013 the market for LOAC devices by end
use segment.
| 
View Cart
